The restorative effect of taurine on experimental nonalcoholic steatohepatitis

Digestive Diseases and Sciences

Volumn 51, Issue 12, 2006, Pages 2225-2234

  Chen, Si Wen ^a   Chen, Yue Xiang ^a   Shi, Jian ^a   Lin, Yong ^a   Xie, Wei Fen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; Fatty liver; Nonalcoholic steatohepatitis; Taurine

Indexed keywords

ADIPONECTIN; AMINOTRANSFERASE; GLUCOSE; MESSENGER RNA; PROCOLLAGEN; TAURINE; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; DRUG EFFECT; FATTY LIVER; GENETICS; GLUCOSE BLOOD LEVEL; HEPATITIS; LIPID PEROXIDATION; LIVER; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; FATTY LIVER; GLUCOSE; HEPATITIS; LIPID PEROXIDATION; LIVER; MALE; ORGAN SIZE; PROCOLLAGEN; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TAURINE; TRANSAMINASES; TRANSFORMING GROWTH FACTOR BETA1; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846957688     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-006-9359-y     Document Type: Article

References (51)

1. Day CP, James OFW (1998) Steatohepatitis: A tale of two "hits"? Gastroenterology 114:842-845
2. Lefkowitch JH, Haythe JH, Regent N (2002) Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod Pathol 15:699-704
3. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40:46-54
4. Lee KS, Buck M, Houglum K, Chojkier M (1995) Activation of hepatic stellate cells by TGF alpha and collagen type l is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461-2468
5. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted proteinAcrp30 enhances hepatic insulin action. Nat Med 7:947-953
6. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881
7. Rajala MW, Scherer PE (2003) Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765-3773
8. Obinata K, Maruyama T, Hayashi M, Watanabe T, Nittono H (1996) Effect of taurine on the fatty liver of children with simple obesity. Adv Exp Med Biol 403:607-613
9. Chen YX, Liu S, Zeng X, Xie WF (2005) A pilot study of the effect of taurine on patients with nonalcoholic fatty liver. Chin J Pract Intern Med 25:249-250
10. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413-1419
11. Nouchi T, Worner TM, Sato S, Lieber CS (1987) Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease. Alcohol Clin Exp Res 11:287-291
12. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467-2474
13. NanjiAA(2004) Animal models of nonalcoholic fatty liver disease and steatohepatitis. Clin Liver Dis 8:559-574, ix
14. Lieber CS, Leo MA,Mak KM, et al. (2004) Model of nonalcoholic steatohepatitis. Am J Clin Nutr 79:502-509
15. Yan CC, Bravo E, Cantafora A (1993) Effect of taurine levels on liver lipid metabolism: an in vivo study in the rat. Proc Soc Exp Biol Med 202:88-96
16. Balkan J, Kanbagli O, Aykac-Toker G, Uysal M (2002) Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats. Biol Pharm Bull 25:1231-1233
17. No authors listed (1993) Age-associated loss of carrier-mediated intestinal taurine transport in cats. Nutr Rev 51:22-23
18. No authors listed (2001) Taurine-monograph. Altern Med Rev 6:78-82
19. Chen YX, Wang SC, Zhao GN, et al. (1992) Membrane stabilization action of taurine on rat hepatic lysosomes. J Fourth Milit Med Univ 13:221-222
20. Chen YX, Wang SC, Zhao GN, et al. (1992) Effect of taurine on calcium uptake and release by isolated rat liver mitochondria. J Fourth Milit Med Univ 13:282-283
21. KozumboWJ, Agarwal S, Koren HS (1992) Breakage and binding of DNA by reaction products of hypochlorous acid with aniline, l-naphthylamine or l-naphthol. Toxicol Appl Pharmacol 115:107-115
22. Dogru-Abbasoglu S, Kanbagli O, Balkan J, Cevikbas U, Aykac-Toker G, Uysal M (2001) The protective effect of taurine against thioacetamide hepatotoxicity of rats. Hum Exp Toxicol 20:23-27
23. Balkan J, Dogru-Abbasoglu S, Kanbagli O, Cevikbas U, Aykac-Toker G, Uysal M (2001) Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum Exp Toxicol 20:251-254
24. Miyazaki T, Karube M, Matsuzaki Y, et al. (2005) Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachlorideinduced hepatic fibrosis. J Hepatol 43:117-125
25. Chen Y, Li S, Zhang X, Zhang Z, Xie W (2002) Amelioration of carbon tetrachloride-induced hepatic fibrosis in rats by treatment with salvia miltiorrhiza and taurine. Zhonghua Gan Zang Bing Za Zhi 10:148-149
26. Refik Mas M, Comert B, et al. (2004) The effect of taurine treatment on oxidative stress in experimental liver fibrosis. Hepatol Res 28:207-215
27. Waters E,Wang JH,Redmond HP,Wu QD, Kay E,Bouchier-Hayes D (2001) Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. Am J Physiol Gastrointest Liver Physiol 280:G1274-G1279
28. Pushpakiran G, Mahalakshmi K, Anuradha CV (2004) Taurine restores ethanol-induced depletion of antioxidants and attenuates oxidative stress in rat tissues. Amino Acids 27:91-96
29. Balkan J, Parldar FH, Dogru-Abbasoglu S, Aykac-Toker G, Uysal M (2005) The effect of taurine or betaine pretreatment on hepatotoxicity and prooxidant status induced by lipopolysaccharide treatment in the liver of rats. Eur J Gastroenterol Hepatol 17:917-921
30. Hagar HH (2004) The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 151:335-343
31. Chen YX (1993) Protective action of taurine on ischemiareperfusion liver injury in rats and its mechanism. Zhonghua Yi Xue Za Zhi 73:276-279, 318-319
32. Chen YX,Wang SC, Zhao GN, Zhang LZ, Tang J, Tang CS (1992) Effect of taurine on lipid peroxidation of isolated rat hepatocellular plasma membrane. J Fourth Milit Med Univ 13:279-281
33. Schuller-Levis GB, Park E (2004) Taurine and its chloramine: modulators of immunity. Neurochem Res 29:117-126
34. Sethupathy S, Elanchezhiyan C, Vasudevan K, Rajagopal G (2002) Antiatherogenic effect of taurine in high fat diet fed rats. Indian J Exp Biol 40:1169-1172
35. Murakami S, Kondo Y, Nagate T (2000) Effect of long-term treatment with taurine in mice fed a high-fat diet: improvement in cholesterol metabolism and vascular lipid accumulation by taurine. Adv Exp Med Biol 483:177-186
36. Balkan J, Kanbagli O, Hatipoglu A, et al. (2002) Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a highcholesterol diet. Biosci Biotechnol Biochem 66:1755-1758
37. Park T, Lee K (1998) Dietary taurine supplementation reduces plasma and liver cholesterol and triglyceride levels in rats fed a high-cholesterol or a cholesterol-free diet. Adv Exp Med Biol 442:319-325
38. Yokogoshi H, Oda H (2002) Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. Amino Acids 23:433-439
39. Murakami S, Kondo Y, Toda Y, et al. (2002) Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70:2355-2366
40. Murakami S, Kondo OY, Tomisawa K (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64:83-91
41. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, BurrellMA(2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280:E827-E847
42. Bajaj M, Suraamornkul S, Piper P, et al. (2004) Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89:200-206
43. Kaser S, Moschen A, Cayon A, et al. (2005) Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 54:117-121
44. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91-100
45. Wang WY (1995) Intestinal endotoxin translocation in endotoxemic rats. Sheng Li Ke Xue Jin Zhan 26:41-44
46. Reeves HL, Friedman SL (2002) Activation of hepatic stellate cells - a key issue in liver fibrosis. Front Biosci 7:D808-D826
47. Wu J, Zern MA (2000) Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 35:665-672
48. Yata Y, Gotwals P, Koteliansky V, Rockey DC (2002) Dosedependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Hepatology 35:1022-1030
49. Tahashi Y, Matsuzaki K, Date M, et al. (2002) Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35:49-61
50. Chen Y, Li S, Zhang X (1999) Taurine inhibits deposition of extracellular matrix in experimental liver fibrosis in rats. Zhonghua Gan Zang Bing Za Zhi 7:165-167
51. Chen YX, Zhang XR, Xie WF, Li S (2004) Effect of taurine on proliferation and apoptosis of hepatic stellate cells in vitro. Hepatobiliary Pancreat Dis Int 3:106-109